World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
BRIEF REPORTSNo Access

FACILE SOLVOTHERMAL SYNTHESIS OF MESOSTRUCTURED CHITOSAN-COATED Fe3O4 NANOPARTICLES AND ITS FURTHER MODIFICATION WITH FOLIC ACID FOR IMPROVING TARGETED DRUG DELIVERY

    https://doi.org/10.1142/S1793292014500817Cited by:5 (Source: Crossref)

    Mesostructured chitosan-coated Fe3O4 nanoparticles (CS-coated Fe3O4 NPs) were synthesized by a facile one-step solvothermal method via using chitosan as a surface-modification agent. Subsequently, the surfaces of CS-coated Fe3O4 NPs were successfully conjugated with folic acid (FA) molecules to obtain FA–CS-coated Fe3O4 NPs for improving targeted drug delivery. The morphology, chemical component and magnetic property of as-prepared composite nanoparticles were characterized by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), dynamic light scattering (DLS), scanning transmission electron microscopy (SEM), transmission electron microscopy (TEM), thermal gravimetric analysis (TGA) and vibrating sample magnetometer (VSM). Furthermore, doxorubicin hydrochloride (DOX) as a model drug was encapsulated for investigating drug release pattern in vitro. The results show that the magnetization saturation value of FA–CS-coated Fe3O4 NPs was about 28.5 emu/g, exhibiting superparamagnetic properties and mesostructure. DOX could be loaded to FA–CS-coated Fe3O4 NPs with high capacity about 27.9%, and the release rate of DOX could be adjusted by the pH value. This work demonstrates that the prepared magnetic nanoparticles have potential applications in the treatment of cancer as targeting drug delivery carriers.